Clinical Trial Update: Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing alpha blocker monotherapy versus 5ARI monotherapy after combination therapy in benign prostatic hyperplasia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Snippet

Sponsor: Samsung Medical Center | Conditions: Benign Prostatic Hyperplasia | Phase 4 | Status: COMPLETED